Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216729 · ClinicalTrials.gov registry record · NA
The Effects of Probiotic Supplementation on State and Trait Stress, Anxiety, and Depression Symptoms in Stressed Adults
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT07216729 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 150 participants.
The verdict
NCT07216729, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The goal of this randomized controlled trial is to learn if supplementation with the probiotic Lactobacillus reuteri DSM 17938 can reduce levels of trait and state perceived stress, anxiety, and depressive symptoms compared to a placebo in a population of stressed adults ages 18-45. This study also investigates several evidence-based moderators of treatment effects, evaluates whether the probiotic caused side effects, and evaluates whether effects endured at 1-month post-supplementation.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Lactobacillus reuteri DSM 17938
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-02-20 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07216729
The ClinicalTrials.gov registry entry for NCT07216729 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07216729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07216729 about?
NCT07216729 is a clinical study titled "The Effects of Probiotic Supplementation on State and Trait Stress, Anxiety, and Depression Symptoms in Stressed Adults". The goal of this randomized controlled trial is to learn if supplementation with the probiotic Lactobacillus reuteri DSM 17938 can reduce levels of trait and state perceived stress, anxiety, and depressive symptoms compared to a placebo in a population of stressed adults ages 18-45. This study also ...
What is the current status of trial NCT07216729?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2023-02-20. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT07216729?
The interventions under investigation include: Placebo (OTHER), Lactobacillus reuteri DSM 17938 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07216729?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.